HUMAN ALLOGENEIC LIVER-DERIVED PROGENITOR CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY AND INFECTIOUS LUNG DISEASES AND SYSTEMIC INFLAMMATION

摘要

The current invention relates to human allogeneic liver-derived progenitor cells (HALPCs), a composition comprising a therapeutically effective amount of said human allogeneic liver-derived progenitor cells or conditioned medium obtainable by culturing said cells in a cell medium for use in the (symptomatic) treatment of inflammatory lung diseases, infectious lung diseases and/or systemic inflammation.